Potent disruptor of actin cytoskeleton in living cells. Forms 1:1 complexes with monomeric actin and caps actin filaments. Selective cytotoxic agent against several human cancer cell lines. Hepatotoxic.
Product Specification
| Concentration: | 10µg/ml |
| |
| Formula: | C47H70O14 |
| |
| MW: | 859.1 |
| |
| Purity: | ≥95% (HPLC) |
| |
| Formulation: | Liquid. In methanol. |
| |
| CAS: | 97564-91-5 |
| |
| Source/Host: | Isolated from Dinophysis spp. |
| |
| Shipping: | SHIPPED ON BLUE ICE |
| |
| Long Term Storage: | -20°C |
| |
| Hazard: | VERY TOXIC. |
| |
Please mouse over
Product Literature References
Cytotoxic compounds from a two-sponge association: J.H. Jung, et al.; J. Nat. Prod.
58, 1722 (1995),
Abstract;
New anti-actin drugs in the study of the organization and function of the actin cytoskeleton: I. Spector, et al.; Microsc. Res. Tech.
47, 18 (1999),
Abstract;
Oocyte-based screening of cytokinesis inhibitors and identification of pectenotoxin-2 that induces Bim/Bax-mediated apoptosis in p53-deficient tumors: H.D. Chae, et al.; Oncogene
24, 4813 (2005),
Abstract;
A structural basis for regulation of actin polymerization by pectenotoxins: J.S. Allingham, et al.; J. Mol. Biol.
371, 959 (2007),
Abstract;
Marine toxins and the cytoskeleton: pectenotoxins, unusual macrolides that disrupt actin: B. Espina & J.A. Rubiolo; Febs J
275, 6082 (2008),
Abstract;